MeSH term
Frequency | Condition_Probility | Adult | 13 | 0.0 |
Alleles | 9 | 0.0 |
Gene Frequency | 10 | 0.0 |
Genotype | 14 | 0.0 |
Humans | 38 | 0.0 |
Polymorphism, Genetic | 8 | 0.0 |
Receptors, Dopamine/*genetics | 11 | 15.0 |
Research Support, Non-U.S. Gov't | 25 | 0.0 |
Dinucleotide Repeats | 2 | 2.0 |
Female | 19 | 0.0 |
Male | 21 | 0.0 |
Middle Aged | 7 | 0.0 |
*Polymorphism, Genetic | 5 | 0.0 |
Receptors, Dopamine D1/*genetics | 14 | 53.0 |
Comparative Study | 4 | 0.0 |
Dopamine/*genetics | 2 | 15.0 |
Linkage (Genetics) | 6 | 0.0 |
Pedigree | 9 | 0.0 |
Psychiatric Status Rating Scales | 3 | 1.0 |
Catechol O-Methyltransferase/genetics | 2 | 6.0 |
Child | 8 | 0.0 |
Dopamine/*metabolism | 2 | 1.0 |
Dopamine beta-Hydroxylase/genetics | 3 | 11.0 |
Family Health | 3 | 0.0 |
Genetic Predisposition to Disease/*genetics | 2 | 0.0 |
Polymorphism, Restriction Fragment Length | 3 | 0.0 |
Receptors, Dopamine D1/genetics | 5 | 83.0 |
Receptors, Dopamine D2/genetics | 4 | 8.0 |
DNA Mutational Analysis | 4 | 0.0 |
Risk Factors | 4 | 0.0 |
Adolescent | 8 | 0.0 |
Case-Control Studies | 3 | 0.0 |
Haplotypes | 5 | 0.0 |
Linkage Disequilibrium | 4 | 0.0 |
Microsatellite Repeats | 3 | 0.0 |
Bipolar Disorder/*genetics | 4 | 3.0 |
Chromosomes, Human, Pair 4 | 2 | 1.0 |
Odds Ratio | 2 | 0.0 |
Schizophrenia/*genetics | 5 | 2.0 |
Attention Deficit Disorder with Hyperactivity/*genetics | 3 | 6.0 |
Brain Chemistry/*genetics | 2 | 4.0 |
*Chromosomes, Human, Pair 4 | 7 | 3.0 |
*Linkage (Genetics) | 4 | 0.0 |
Receptors, Dopamine D2/*genetics | 2 | 0.0 |
Lod Score | 5 | 0.0 |
Carrier Proteins/genetics | 2 | 0.0 |
DNA Primers | 4 | 0.0 |
England | 2 | 1.0 |
*Membrane Glycoproteins | 5 | 0.0 |
*Membrane Transport Proteins | 3 | 0.0 |
*Nerve Tissue Proteins | 5 | 1.0 |
Amino Acid Sequence | 3 | 0.0 |
Animals | 7 | 0.0 |
Cloning, Molecular | 5 | 0.0 |
Molecular Sequence Data | 11 | 0.0 |
Child, Preschool | 2 | 0.0 |
Chromosome Mapping | 6 | 0.0 |
Dopamine beta-Hydroxylase/*genetics | 2 | 4.0 |
Base Sequence | 12 | 0.0 |
Genes, Dominant | 2 | 0.0 |
Genetic Markers | 4 | 0.0 |
Schizophrenia/genetics | 2 | 7.0 |
*Mutation | 2 | 0.0 |
Research Support, U.S. Gov't, P.H.S. | 8 | 0.0 |
Sequence Alignment | 2 | 0.0 |
Sex Factors | 2 | 0.0 |
Longitudinal Studies | 2 | 0.0 |
Phenotype | 2 | 0.0 |
Dopamine/*physiology | 2 | 2.0 |
Receptors, Dopamine/genetics | 2 | 16.0 |
*Receptors, Dopamine D1 | 7 | 77.0 |
Multigene Family/*genetics | 2 | 1.0 |
Pseudogenes/*genetics | 2 | 2.0 |
Restriction Mapping | 2 | 0.0 |
Sequence Analysis, DNA | 2 | 0.0 |
Hamsters | 2 | 0.0 |
Hybrid Cells | 2 | 0.0 |
Polymerase Chain Reaction | 7 | 0.0 |
DNA, Satellite/*genetics | 2 | 3.0 |
Attention Deficit Disorder with Hyperactivity/epidemiology/*genetics | 2 | 40.0 |
*Linkage Disequilibrium | 2 | 1.0 |
Membrane Transport Proteins/genetics | 2 | 6.0 |
Cell Line | 2 | 0.0 |
Oligodeoxyribonucleotides | 2 | 0.0 |
Sequence Homology, Nucleic Acid | 2 | 0.0 |
Gene Library | 2 | 0.0 |
